These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3800150)

  • 1. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Jan; 135(1):241-4. PubMed ID: 3800150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipratropium bromide treatment of experimental rhinovirus infection.
    Gaffey MJ; Hayden FG; Boyd JC; Gwaltney JM
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1644-7. PubMed ID: 2855297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Sastre A; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Sep; 136(3):556-60. PubMed ID: 3307567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold.
    Borum P; Olsen L; Winther B; Mygind N
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.
    Sperber SJ; Sorrentino JV; Riker DK; Hayden FG
    Bull N Y Acad Med; 1989 Jan; 65(1):145-60. PubMed ID: 2557947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
    Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
    JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
    Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
    N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds.
    Doyle WJ; Riker DK; McBride TP; Hayden FG; Hendley JO; Swarts JD; Gwaltney JM
    Ann Otol Rhinol Laryngol; 1993 Jul; 102(7):521-7. PubMed ID: 8392820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
    Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
    Hayden FG; Kaiser DL; Albrecht JK
    Antimicrob Agents Chemother; 1988 Feb; 32(2):224-30. PubMed ID: 2834996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.
    Farr BM; Gwaltney JM; Hendley JO; Hayden FG; Naclerio RM; McBride T; Doyle WJ; Sorrentino JV; Riker DK; Proud D
    J Infect Dis; 1990 Nov; 162(5):1173-7. PubMed ID: 2172395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinacea purpurea for prevention of experimental rhinovirus colds.
    Sperber SJ; Shah LP; Gilbert RD; Ritchey TW; Monto AS
    Clin Infect Dis; 2004 May; 38(10):1367-71. PubMed ID: 15156472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold.
    Avila PC; Abisheganaden JA; Wong H; Liu J; Yagi S; Schnurr D; Kishiyama JL; Boushey HA
    J Allergy Clin Immunol; 2000 May; 105(5):923-32. PubMed ID: 10808173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
    Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
    J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal pirodavir (R77,975) treatment of rhinovirus colds.
    Hayden FG; Hipskind GJ; Woerner DH; Eisen GF; Janssens M; Janssen PA; Andries K
    Antimicrob Agents Chemother; 1995 Feb; 39(2):290-4. PubMed ID: 7726484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.
    Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB
    Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.
    Peterson KM; O'Shea M; Stam W; Mohede IC; Patrie JT; Hayden FG
    Antivir Ther; 2009; 14(1):33-43. PubMed ID: 19320235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on the nasal mucosa of upper respiratory viruses (common cold).
    Winther B
    Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.